A Dwindling Pandemic Spells Disaster for Rite Aid Stock…could it get even worse?
While Rite Aid had a good run during the pandemic, it appears the stock is headed back towards the bottom - as the company reports another quarter of poor results. The retail drug store chain lost over $300 million in the fiscal 2nd quarter. This resulted in a net loss per share of $6.07, way up from the previous [...]
Cheniere Energy Powers Ahead in the Liquefied Natural Gas Market
On Thursday, September 28, LNG had a huge up day with a $10.60 gain (6.95%) after hitting an intraday low of $147.70 on September 26. The high for the year was on September 14 at $178.62. The closing price pierced its 50-day moving average and closed well above it. Over the past year, energy-related stocks have been the leading [...]
What Biogen’s Alzheimer’s Drug Results Means for the Company’s Stock
Yesterday, we discussed how Crispr stock enjoyed a short-lived jump ahead of seeking FDA approval for their gene therapy drug. But today, we’re here to talk about a drug company that has experienced a much larger spike as a result of positive news: Biogen. Biogen is engaged in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. And [...]
Crispr Stock Jumps after Seeking FDA Approval for Gene Therapy Drug…Should You Buy Now?
While many stocks are moving downwards this morning, one stock has made a nice 5% jump since the market opened - and that’s Crispr. The company is engaged in the development of transformative drugs based on gene therapy. And news just released that they are finally on the path to seeking FDA approval for their new drug. But - [...]
What Amazon Announcing Second Prime Day Sale Means for Investors!!
It was announced early this morning that Amazon is adding another Prime Day sale to their calendar. Prime Day has historically come once a year and has been the most lucrative day for the company - and its sellers. Revenue on Prime Day has even surpassed Black Friday/Cyber Monday sales in the past. This new sale is known as [...]
LLY is Upgraded by Analysts Ahead of New Drug…But What Does VectorVest Rate the Stock?
You’d be hard-pressed to find a stock that’s shown positive growth over the past year - but Eli Lilly is one of them. The pharmaceutical developer & manufacturer has had a great year - up 35% in the last 365 days. Even looking at the bigger picture, this stock has been a high-performer. This is driven by the company’s [...]